Alice Durand

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Oliver Illini, Maximilian J. Hochmair, Hannah Fabikan et al. · Therapeutic Advances in Medical Oncology · 2021 · 44 citations · Full text

ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study

Laura Gérard, Jessica Garcia, Arnaud Gauthier et al. · Neuroendocrinology · 2020 · 29 citations

Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d’Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network

Julien Hadoux, Christina Kanaan, Alice Durand et al. · European Journal of Cancer · 2021 · 23 citations · Full text

Tumor Biology, Endocrine Oncology, Platinum Etoposide +11

Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokinetics.

Anthony Gonçalvès, Jacques Camerlo, Bun H et al. · PubMed · 2001 · 20 citations

Belzutifan for Advanced Pheochromocytoma or Paraganglioma

Camilo Jiménez, Mikkel Andreassen, Alice Durand et al. · New England Journal of Medicine · 2025 · 10 citations · Full text